LC-ESI/MS/MS
Identification and characterization of in vivo, in vitro and reactive metabolites of vandetanib using LC–ESI–MS/MS
16
Simultaneous Determination of Ten Endocrine Hormone Disrupters in Water Using SPE/LC (ESI)MS MS
12
Measurement of methionine level with the LC-ESI-MS/MS method in schizophrenic patients
9
Development and Validation of a LC-ESI-MS/MS Based Bioanalytical Method for Dapagliflozin and Saxagliptin in Human Plasma
10
Phytochemical Study of Nothapodytes foetida by LC-ESI-MS
10
Fast LC-ESI-MS/MS analysis and influence of sampling conditions for gut metabolites in plasma and serum
11
Phytochemical Diversity in Rhizomes of Three Reynoutria Species and their Antioxidant Activity Correlations Elucidated by LC-ESI-MS/MS Analysis.
44
Estimation of Ribociclib in Human Plasma Samples by LC ESI MS/MS
6
Rapid LC ESI MS MS Method for the Simultaneous Determination of Sitagliptin and Pioglitazone in Rat Plasma and Its Application to Pharmacokinetic Study
10
Proteome analysis of excretory-secretory proteins of Entamoeba histolytica HM1:IMSS via LC–ESI–MS/MS and LC–MALDI–TOF/TOF
10
Simultaneous quantification of six major flavonoids from Fructus sophorae by LC-ESI-MS/MS and statistical analysis
9
Picogram Level Quantification of Grazoprevir and Elbasvir with Deuterated Internal Standards in Human Plasma Samples by LC–ESI-MS/MS
8
Picogram level quantification of Afatinib in human plasma samples by LC–ESI MS/MS
6
A validated LC-ESI-MS/MS method for the quantification of Selegiline HCl in bulk and pharmaceutical formulation
5
PICOGRAM LEVEL QUANTIFICATION OF VARENICLINE IN HUMAN PLASMA SAMPLES BY LC–ESI MS/MS
8
Liquid Chromatography Tandem Mass Spectrometry Method for Determination of Anti Diabetic Drug Repaglinide in Human Plasma
10
Development and evaluation of an immuno-MALDI (iMALDI) assay for angiotensin I and the diagnosis of secondary hypertension
9
Guarapiranga Reservoir—Pharmaceuticals and Historical Urban Occupation in a Water Source
17
In Vitro Metabolism Study of Brevetoxins by LC-ESI-MS
41
The Quest for Renal Disease Proteomic Signatures: Where Should We Look?
7